Listed

Audioeye Inc: Form 10-Q for the period ended Jun 30, 2024

Filed with the SEC on Jul 29, 2024 and accepted by EDGAR at Jul 29, 2024, 12:35 ET.

Share

Management's discussion and analysis

As filed, 27,388 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

The following Management’s Discussion and Analysis of Financial Condition and Results of Operations, or MD&A, should be read in conjunction with our consolidated financial statements and related notes in Part I, Item 1 of this report.

As used in this quarterly report, the terms “we,” “us,” “our” and similar references refer to AudioEye, Inc., unless otherwise indicated.

Cautionary Note Regarding Forward-Looking Statements

This Quarterly Report on Form 10-Q contains forward-looking statements within the meaning of the federal securities laws, including Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). In some cases, you may be able to identify forward-looking statements by terms such as “may,” “should,” “will,” “forecasts,” “expects,” “plans,” “anticipates,” “believes,” “estimates,” “predicts,” “projects,” “potential” or “continue,” the negative of these terms and other similar expressions that predict or indicate future events or trends or that are not statements of historical matters. These forward-looking statements relate to our future plans, objectives, expectations, intentions and financial performance and the assumptions that underlie these statements, and are based only on our current beliefs, expectations and assumptions regarding the future of our business, future plans and strategies, projections, anticipated events and trends, the economy and other future conditions and speak only as of the date on which they are made.

Because these forward-looking statements involve known and unknown risks and uncertainties, there are important factors that could cause actual results, events or developments to differ materially from those expressed or implied by these forward-looking statements, including our plans, objectives, expectations and intentions and other factors discussed in “Part I, Item 1A. Risk Factors” contained in our most recent Annual Report on Form 10-K and any subsequent Quarterly Reports on Form 10-Q. Risk factors that could cause actual results to differ from those contained in the forward-looking statements include but are not limited to risks related to:

  • the uncertain market acceptance of our existing and future products;
  • our need for, and the availability of, additional capital in the future to fund our operations and the development of new products;
  • the success, timing and financial consequences of new strategic relationships or licensing agreements we may enter into;
  • rapid changes in Internet-based applications that may affect the utility and commercial viability of our products;
  • the timing and magnitude of expenditures we may incur in connection with our ongoing product development activities;
  • judicial applications of accessibility laws to the internet;
  • the level of competition from our existing competitors and from new competitors in our marketplace; and
  • the regulatory environment for our products and services.

Readers of this report are cautioned not to rely on these forward-looking statements, since there can be no assurance that these forward-looking statements will prove to be accurate. Forward-looking statements speak only as of the date they are made, and we expressly disclaim any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. You are advised, however, to consult any further disclosures we make on related subjects in our subsequent Quarterly Reports on Form 10-Q and Current Reports on Form 8-K. This cautionary note is applicable to all forward-looking statements contained in this report.

AudioEye Solutions

At its core, AudioEye’s offering provides an always-on testing, remediation, and monitoring solution that continually improves conformance with Web Content Accessibility Guidelines (“WCAG”). This in turn helps businesses and organizations comply with WCAG standards as well as applicable U.S. and foreign accessibility laws. Our technology is capable of immediately identifying and fixing most of the common accessibility errors and addresses a wide range of disabilities including dyslexia, color blindness, epilepsy and more. AudioEye also offers additional solutions to provide for enhanced compliance and accessibility, including periodic auditing, human assisted technological remediations and legal support services. Our solutions may be purchased through a subscription service on a month-to-month basis or with one or multi-year terms. We also offer PDF remediation services and mobile application and audit reporting services to help our customers with their digital accessibility needs.

Intellectual Property

Our intellectual property is primarily comprised of copyrights, trademarks, trade secrets, issued patents and pending patent applications. We have a patent portfolio comprised of twenty-three (23) issued patents in the United States and three (3) pending US patent applications. The commercial value of these patents is unknown.

We plan to continue to invest in research and development and expand our portfolio of proprietary intellectual property.

Our Annual Report filed on Form 10-K for the year ended December 31, 2023 as filed with the SEC on March 7, 2024 provides additional information about our business and operations.

Legal and Regulatory Framework Update

On April 24, 2024, the U.S. Department of Justice (“DOJ”) published a rule to add specific requirements about web and mobile application accessibility under Title II of the ADA that would apply to state and local governments. On May 9, 2024, the U.S. Department of Health and Human Services (“HHS”) published a rule to add, among other things, specific requirements about web and mobile application accessibility under Section 504 of the Rehabilitation Act that would apply to recipients of Federal financial assistance.

Executive Overview

AudioEye is an industry-leading digital accessibility platform delivering Americans with Disabilities Act (“ADA”) and WCAG compliance at scale. Our solutions advance accessibility with patented technology that reduces barriers, expands access for individuals with disabilities, and enhances the user experience for a broader audience. In the three months ended June 30, 2024, we continued to focus on product innovation, expanding revenue and managing expenses.

We have two sales channels to deliver our product, the Partner and Marketplace channel and the Enterprise channel. AudioEye continues to focus on recurring revenue growth in both channels, while still offering our mobile application reporting services and PDF remediation services that provide non-recurring revenue. For the six months ended June 30, 2024, total revenue increased by 6% over the prior year comparable period. As of June 30, 2024, Annual Recurring Revenue (“ARR”) was approximately $33.3 million, which represented an increase of 12% year-over-year. Refer to Other Key Operating Metrics below for details on how we calculate ARR.

As of June 30, 2024, AudioEye had approximately 121,000 customers, a 16% increase from 104,000 customers at June 30, 2023. The increase in customer count is attributed to both our Partner and Marketplace and Enterprise channels.

In the six months ended June 30, 2024, revenue from our Partner and Marketplace channel grew 11% over the prior year comparable period. This channel represented about 60% of ARR at the end of June 2024. In six months ended June 30, 2024, total Enterprise channel revenue remained consistent with the prior year comparable period. The Enterprise channel represented about 40% of ARR at the end of June 2024.

We had one customer (including the customer’s affiliates reflecting multiple contracts and a partnership with the Company) which accounted for approximately 16% of our total revenue in each of the six months ended June 30, 2024 and 2023.

The Company continued to invest in research and development in the second quarter of 2024. Total research and development cost, as defined under Research and Development Expenses section in the Results of Operations below, was 21% of total revenue in the six months ended June 30, 2024. Total research and development cost decreased from the prior year comparable period primarily due to the completion of significant initiatives in research and development.

While revenue increased 6% in the six months ended June 30, 2024, selling and marketing expense and general and administrative expense decreased from the prior year comparable period. This decrease was mainly driven by efficiencies in selling and marketing and lower stock compensation expense.

We provide further commentary on our Results of Operation below.

Results of Operations

Our unaudited consolidated financial statements are stated in United States Dollars and are prepared in accordance with United States Generally Accepted Accounting Principles (“U.S. GAAP” or “GAAP”). The discussion of the results of our operations compares the three and six months ended June 30, 2024 with the three and six months ended June 30, 2023.

Our results of operations in these interim periods are not necessarily indicative of the results which may be expected for any subsequent period. Due to rounding, numbers presented throughout this document may not add up precisely to the totals provided and percentages may not precisely reflect the absolute figures.

(in thousands)

​ ​ ​ ​ ​ ​ Three months ended June 30, 2024 ​ ​ ​ 2023 ​ ​ ​ ​ Change $% ​ ​ ​
Revenue ​ $8,470 ​ $7,836 ​ $634 ​ 8%
Cost of revenue ​ (1,764) ​ ​ (1,787) ​ ​ 23 ​ (1)%
Gross profit ​ 6,706 ​ ​ 6,049 ​ ​ 657 ​ 11%
Operating expenses: ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​
Selling and marketing ​ 2,971 ​ ​ 3,253 ​ ​ (282) ​ (9)%
Research and development ​ 1,221 ​ ​ 2,033 ​ ​ (812) ​ (40)%
General and administrative ​ 3,011 ​ ​ 2,791 ​ ​ 220 ​ 8%
Total operating expenses ​ 7,203 ​ ​ 8,077 ​ ​ (874) ​ (11)%
Operating loss ​ (497) ​ ​ (2,028) ​ ​ 1,531 ​ (75)%
Interest income (expense), net ​ (238) ​ ​ 55 ​ ​ (293) ​ (533)%
Net loss ​ $(735) ​ $(1,973) ​ $1,238 ​ (63)%

(in thousands)

​ ​ ​ ​ ​ ​ Six months ended June 30, 2024 ​ ​ ​ 2023 ​ ​ ​ Change $​% ​ ​ ​
Revenue ​ $16,553 ​ $15,608 ​ $945 ​ 6%
Cost of revenue ​ (3,525) ​ (3,489) ​ (36) ​ 1%
Gross profit ​ 13,028 ​ 12,119 ​ 909 ​ 8%
Operating expenses: ​ ​ ​ ​ ​
Selling and marketing ​ 5,974 ​ 6,496 ​ (522) ​ (8)%
Research and development ​ 2,543 ​ 3,779 ​ (1,236) ​ (33)%
General and administrative ​ 5,639 ​ 5,926 ​ (287) ​ (5)%
Total operating expenses ​ 14,156 ​ 16,201 ​ (2,045) ​ (13)%
Operating loss ​ (1,128) ​ (4,082) ​ 2,954 ​ (72)%
Interest income (expense), net ​ (436) ​ 98 ​ (534) ​ (545)%
Net loss ​ $(1,564) ​ $(3,984) ​ $2,420 ​ (61)%

Revenue

The following tables present our revenues disaggregated by sales channel:

(in thousands)

​ ​ ​ ​ ​ Three months ended June 30, 2024 ​ ​ ​ 2023 ​ ​ ​ Change $% ​ ​ ​ ​
Partner and Marketplace ​ $4,970 ​ $4,417 ​ $553 ​ 13%
Enterprise ​ 3,500 ​ ​ 3,419 ​ ​ 81 ​ 2%
Total revenues ​ $8,470 ​ $7,836 ​ $634 ​ 8%

(in thousands)

​ ​ ​ ​ ​ ​ Six months ended June 30, 2024 ​ ​ ​ 2023 ​ ​ ​ Change $% ​ ​ ​
Partner and Marketplace ​ $9,704 ​ $8,760 ​ $944 ​ 11%
Enterprise ​ 6,849 ​ 6,848 ​ 1 ​ —%
Total revenues ​ $16,553 ​ $15,608 ​ $945 ​ 6%

Partner and Marketplace channel consists of our CMS partners, platform & agency partners, authorized resellers and the Marketplace. This channel serves small & medium sized businesses that are on a partner or reseller’s web-hosting platform or that purchase our solutions from our Marketplace.

Enterprise channel consists of our larger customers and organizations, including those with non-platform custom websites, who generally engage directly with AudioEye sales personnel for custom pricing and solutions. This channel also includes federal, state and local government agencies.

For the three and six months ended June 30, 2024, total revenue increased by 8% and 6%, respectively, over the prior year comparable periods. The increase in Partner and Marketplace channel revenue was the result of continued expansion with existing partners and execution of new partnerships agreements in the period. The increase in Enterprise channel revenue for the three months ended June 30, 2024 was driven primarily by an increase in Enterprise customers.

Cost of Revenue and Gross Profit

(in thousands)

​ ​ ​ ​ ​ ​ Three months ended June 30, 2024 ​ ​ ​ 2023 ​ ​ ​ Change $% ​ ​ ​
Revenue ​ $8,470 ​ $7,836 ​ $634 ​ 8%
Cost of Revenue ​ (1,764) ​ ​ (1,787) ​ ​ 23 ​ (1)%
Gross profit ​ $6,706 ​ $6,049 ​ $657 ​ 11%

(in thousands)

​ ​ ​ ​ ​ ​ Six months ended June 30, 2024 ​ ​ ​ ​ 2023 ​ ​ ​ ​ Change $% ​ ​ ​
Revenue ​ $16,553 ​ $15,608 ​ $945 ​ 6%
Cost of Revenue ​ (3,525) ​ (3,489) ​ (36) ​ 1%
Gross profit ​ $13,028 ​ $12,119 ​ $909 ​ 8%

Cost of revenue consists primarily of compensation and related benefits costs for our customer experience team, as well as a portion of our technology operations team that supports the delivery of our services, fees paid to our managed hosting and other third-party service providers, amortization of capitalized software development costs and patent costs, and allocated overhead costs.

For the three and six months ended June 30, 2024, cost of revenue remained consistent with the prior year comparable periods.

For the three and six months ended June 30, 2024, gross profit increased by 11% and 8% over the prior year comparable periods. The increase in gross profit was a result of increased revenue.

Selling and Marketing Expenses

(in thousands)

​ ​ ​ ​ ​ Three months ended June 30, 2024 ​ ​ ​ 2023 ​ ​ ​ Change $% ​ ​ ​
Selling and marketing ​ $2,971 ​ $3,253 ​ $(282) ​ (9)%

(in thousands)

​ ​ ​ ​ ​ ​ Six months ended June 30, 2024 ​ ​ ​ 2023 ​ ​ ​ Change $% ​ ​ ​
Selling and marketing ​ $5,974 ​ $6,496 ​ $(522) (8)%

Selling and marketing expenses consist primarily of compensation and benefits related to our sales and marketing staff, as well as third-party advertising and marketing expenses.

For the three and six months ended June 30, 2024, selling and marketing expenses decreased by 9% and 8%, respectively, over the prior year comparable periods. The decrease in selling and marketing expenses resulted primarily from a reduction in online media and third-party marketing expenses and a reduction to stock compensation expense.

Research and Development Expenses

(in thousands)

​ ​ ​ ​ ​ Three months ended June 30, 2024 ​ ​ ​ 2023 ​ ​ ​ Change $% ​ ​ ​
Research and development expense ​ $1,221 ​ $2,033 ​ $(812) ​ (40)%
Plus: Capitalized research and development cost ​ 457 ​ ​ 526 ​ ​ (69) ​ (13)%
Total research and development cost ​ $1,678 ​ $2,559 ​ $(881) ​ (34)%

(in thousands)

​ ​ ​ ​ ​ ​ Six months ended June 30, 2024 ​ ​ ​ 2023 ​ ​ ​ Change $% ​ ​ ​
Research and development expense ​ $2,543 ​ $3,779 ​ $(1,236) ​ (33)%
Plus: Capitalized research and development cost ​ 947 ​ 999 ​ (52) ​ (5)%
Total research and development cost ​ $3,490 ​ $4,778 ​ $(1,288) ​ (27)%

Research and development (“R&D”) expenses consist primarily of compensation and related benefits, independent contractor costs, and an allocated portion of general overhead costs related to our employees involved in research and development activities. Total research and development cost includes the amount of research and development expense reported within operating expenses as well as development cost that was capitalized during the fiscal period.

For the three and six months ended June 30, 2024, research and development expense decreased by 40% and 33%, respectively, over the prior year comparable periods. This decrease was driven by lower personnel cost associated with a realignment in our product and development teams following the completion of significant initiatives in R&D. For the three and six months ended June 30, 2024, capitalized research and development cost decreased by 13% and 5%, respectively, over the prior year comparable periods. The decrease to capitalized research cost was the result of engineering personnel spending less time on product development than in the prior year comparable periods. For the three and six months ended June 30, 2024, total research and development cost, which includes both R&D expenses and capitalized R&D costs, decreased by 34% and 27%, respectively, over the prior year comparable periods.

General and Administrative Expenses

(in thousands)

​ ​ ​ ​ ​ ​ Three months ended June 30, 2024 ​ ​ ​ 2023 ​ ​ ​ ​ Change $% ​ ​ ​ ​
General and administrative ​ $3,011 ​ $2,791 ​ $220 ​ 8%

(in thousands)

​ ​ ​ ​ ​ ​ Six months ended June 30, 2024 ​ ​ ​ 2023 ​ ​ ​ Change $% ​ ​ ​
General and administrative ​ $5,639 ​ $5,926 ​ $(287) ​ (5)%

General and administrative expenses consist primarily of compensation and benefits related to our executives, directors and corporate support functions, general corporate expenses including legal fees, and occupancy costs.

For the three months ended June 30, 2024, general and administrative expenses increased by 8% over the prior year comparable period. The increase in general and administrative expenses was due primarily to higher stock compensation expense and litigation expenses, partially offset by lower personnel costs and the absence of valuation adjustments to contingent consideration in the second quarter of 2024.

For the six months ended June 30, 2024, general and administrative expenses decreased by 5% over the prior year comparable periods. The decrease in general and administrative expenses was due primarily to lower personnel costs and a reduction in valuation adjustments to contingent consideration, partially offset by an increase in litigation expenses.

Interest Income (Expense)

(in thousands)

​ ​ ​ ​ ​ Three months ended June 30, 2024 ​ ​ ​ 2023 ​ ​ ​ Change $% ​ ​ ​
Interest income (expense), net ​ $(238) ​ $55 ​ $(293) ​ (533)%

(in thousands)

​ ​ ​ ​ ​ ​ Six months ended June 30, 2024 ​ ​ ​ 2023 ​ ​ ​ Change $% ​ ​ ​
Interest income (expense), net ​ $(436) ​ $98 ​ $(534) ​ (545)%

For the three and six months ended June 30, 2024, interest expense, net consisted primarily of interest on our term loan borrowed in the fourth quarter of 2023, which was partially offset by interest income from investment in money market funds. For the three and six months ended June 30, 2023, interest income, net consisted primarily of income from investment in money market funds.

Other Key Operating Metrics

We consider annual recurring revenue (“ARR”) as a key operating metric and a key indicator of our overall business. We also use ARR as one of the primary methods for planning and forecasting overall expectations and for evaluating, on at least a quarterly and annual basis, actual results against such expectations.

We define ARR as the sum of (i) for our Enterprise channel, the total of the annualized recurring fee at the date of determination under each active contract, plus (ii) for our Partner and Marketplace channel, the annual or monthly recurring fee for all active customers at the date of determination, in each case, assuming no changes to the subscription, multiplied by 12 if applicable. Recurring fees are defined as revenues expected to be generated from services typically offered as a subscription service such as our automation and platform, periodic auditing, human-assisted technological remediations, legal support and professional service offerings and other services that reoccur on a multi-year contract. This determination includes both annual and monthly contracts for recurring products. Some of our contracts are terminable prior to the expected term, which may impact future ARR. ARR excludes non-recurring fees, which are defined as revenue expected to be generated from services typically not offered as a subscription service such as our PDF remediation services business, one-time mobile application reports, and other miscellaneous services that are offered as non-subscription services or are expected to be one-time in nature. As of June 30, 2024, ARR was $33.3 million, which represents an increase of 12% year-over-year, driven by growth in both our Partner and Marketplace channel and Enterprise channel.

Liquidity and Capital Resources

Working Capital

(in thousands)

​ ​ ​ ​ June 30, 2024 ​ ​ ​ December 31, 2023
Current assets ​ $11,556 ​ $14,776
Current liabilities ​ (9,949) ​ (11,529)
Working capital ​ $1,607 ​ $3,247

As of June 30, 2024, we had $5,086,000 in cash and working capital of $1,607,000. The $1.6 million decrease in working capital in the six months ended June 30, 2024 was primarily due to the use of $2.02 million in cash to repurchase 299,371 shares of our common stock.

In November 2023, the Board of Directors adopted a share repurchase program authorizing the repurchase of up to $5 million of our common stock through December 31, 2025. The stock repurchase program may be suspended or discontinued at any time and does not commit the Company to repurchase any dollar amount or particular number of shares of stock. Shares repurchased under the program are subsequently retired and restored to the status of authorized but unissued shares of common stock. As of June 30, 2024, we had $1.86 million remaining for the repurchase of shares.

In the second quarter of 2024, the Company initiated an At The Market offering (“ATM offering”), under which we issued 39,646 shares of our common stock and raised $663,000, net of transaction expenses. As of June 30, 2024, offering costs included in accounts payable totaled $100,000.

In the second quarter of 2024, we made the $2.4 million cash payment to settle the contingent consideration associated with the BOIA acquisition in full. As of June 30, 2024, we had $7.0 million in noncurrent term loan which matures on November 30, 2026.

As of June 30, 2024, we had no off-balance sheet arrangements, and we believe that the Company has sufficient liquidity to continue as a going concern through the next twelve months.

While the Company has been successful in raising capital, there is no assurance that it will be successful at raising additional capital in the future. Additionally, if the Company’s plans are not achieved and/or if significant unanticipated events occur, the Company may have to further modify its business plan, which may require us to raise additional capital or reduce expenses.

Cash Flows

(in thousands)

​ ​ ​ ​ ​ Six months ended June 30, 2024 ​ ​ ​ 2023
Net cash provided by (used in) operating activities ​ $613 ​ $(191)
Net cash used in investing activities ​ (1,035) ​ ​ (1,056)
Net cash used in financing activities ​ (3,728) ​ ​ (1,340)
Net decrease in cash ​ $(4,150) ​ $(2,587)

For the six months ended June 30, 2024, in relation to the prior year comparable period, cash provided by operating activities increased primarily due cost efficiencies associated with lower personnel cost following a realignment in our product and development teams, as well as lower online media and third-party marketing expenses.

For the six months ended June 30, 2024, in relation to the prior year comparable period, cash used in investing activities decreased primarily due to lower software development costs.

For the six months ended June 30, 2024, in relation to the prior year comparable period, cash used in financing activities increased primarily due to common stock repurchases totaling $2.02 million, as well as higher payouts towards the contingent consideration in connection with the acquisition of BOIA. In the six months ended June 30, 2024, payments towards our contingent consideration totaled $2,387,000, of which $1,677,000 and $710,000 are classified as cash used in financing and operating activities, respectively. In the six months ended June 30, 2023, payments towards our contingent consideration totaled $974,000, of which $908,000 and $66,000 are classified as cash used in financing and operating activities, respectively.

Critical Accounting Policies and Estimates

The discussion and analysis of our financial condition and results of operations are based upon our consolidated financial statements, which have been prepared in accordance with the accounting principles generally accepted in the United States. The preparation of consolidated financial statements requires management to make estimates and assumptions that affect the amounts reported and disclosed in our consolidated financial statements and the accompanying notes. Actual results could differ materially from these estimates under different assumptions or conditions.

Our critical accounting estimates, as described in our Annual Report on Form 10-K for the fiscal year ended December 31, 2023, relate to stock-based compensation and goodwill, intangible assets and contingent consideration recognized in connection with a business combination. There have been no material changes to our critical accounting policies and estimates as disclosed in our Annual Report on Form 10-K for the fiscal year ended December 31, 2023.

Controls and procedures

As filed, 2,510 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

Evaluation of Disclosure Controls and Procedures

The Company maintains disclosure controls and procedures that are designed to ensure that there is reasonable assurance that the information required to be disclosed in the Company’s reports under the Securities Exchange Act of 1934, as amended (the “Exchange Act”), is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms, and that such information is accumulated and communicated to the Company’s management, including its Principal Executive Officer and Principal Financial Officer, as appropriate, to allow timely decisions regarding required disclosure based on the definition of “disclosure controls and procedures” in Exchange Act Rules 13a-15(e) and 15d-15(e). In designing and evaluating the disclosure controls and procedures, management recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired control objectives, and management necessarily was required to apply its judgment in evaluating the cost-benefit relationship of possible controls and procedures. In addition, projections of any evaluation of effectiveness of our disclosure controls and procedures to future periods are subject to the risk that controls or procedures may become inadequate because of changes in conditions, or that the degree of compliance with the controls or procedures may deteriorate.

As of the end of the period covered by this report, an evaluation was performed under the supervision and with the participation of the Company’s senior management, including the Chief Executive Officer (Principal Executive Officer) and Chief Financial Officer (Principal Financial Officer), of the effectiveness of the design and operation of the Company’s disclosure controls and procedures to provide reasonable assurance of achieving the desired objectives of the disclosure controls and procedures. Based on that evaluation, our Chief Executive Officer and Chief Financial Officer have concluded that our disclosure controls and procedures were effective as of June 30, 2024.

Changes in Internal Controls over Financial Reporting

During the quarter ended June 30, 2024, there were no material changes in our internal control over financial reporting during the most recently completed fiscal quarter that have materially affected or are reasonably likely to materially affect our internal control over financial reporting.

Risk factors

As filed, 631 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

You should carefully consider the factors discussed in Part I, Item 1A “Risk Factors” in our Annual Report on Form 10-K for the year ended December 31, 2023 (“2023 Form 10-K”), which could materially affect our business, financial condition and results of operations. There have been no material changes to the risk factors set forth in the 2023 Form 10-K. The risks described in our 2023 Form 10-K are not the only risks we face. Additional risks and uncertainties not currently known to us or that we currently deem to be immaterial also may materially adversely affect our business, financial condition or results of operations.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2024-06-30. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Revenue3 months2024-04-01 to 2024-06-30$8.5mus-gaap:Revenues
Revenue6 months2024-01-01 to 2024-06-30$16.6mus-gaap:Revenues
Cost of revenue3 months2024-04-01 to 2024-06-30$1.8mus-gaap:CostOfRevenue
Cost of revenue6 months2024-01-01 to 2024-06-30$3.5mus-gaap:CostOfRevenue
Gross profit3 months2024-04-01 to 2024-06-30$6.7mus-gaap:GrossProfit
Gross profit6 months2024-01-01 to 2024-06-30$13.0mus-gaap:GrossProfit
Research and development3 months2024-04-01 to 2024-06-30$1.2mus-gaap:ResearchAndDevelopmentExpense
Research and development6 months2024-01-01 to 2024-06-30$2.5mus-gaap:ResearchAndDevelopmentExpense
Operating income3 months2024-04-01 to 2024-06-30−$497.0kus-gaap:OperatingIncomeLoss
Operating income6 months2024-01-01 to 2024-06-30−$1.1mus-gaap:OperatingIncomeLoss
Net income3 months2024-04-01 to 2024-06-30−$735.0kus-gaap:NetIncomeLoss
Net income6 months2024-01-01 to 2024-06-30−$1.6mus-gaap:NetIncomeLoss
Diluted EPS3 months2024-04-01 to 2024-06-30−$0.06us-gaap:EarningsPerShareDiluted
Diluted EPS6 months2024-01-01 to 2024-06-30−$0.13us-gaap:EarningsPerShareDiluted
Basic EPS3 months2024-04-01 to 2024-06-30−$0.06us-gaap:EarningsPerShareBasic
Basic EPS6 months2024-01-01 to 2024-06-30−$0.13us-gaap:EarningsPerShareBasic
Diluted shares (weighted)3 months2024-04-01 to 2024-06-3011,703,000 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Diluted shares (weighted)6 months2024-01-01 to 2024-06-3011,706,000 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Operating cash flow6 months2024-01-01 to 2024-06-30$613.0kus-gaap:NetCashProvidedByUsedInOperatingActivities
Capital expenditure6 months2024-01-01 to 2024-06-30$75.0kus-gaap:PaymentsToAcquirePropertyPlantAndEquipment
Share repurchases6 months2024-01-01 to 2024-06-30$2.0mus-gaap:PaymentsForRepurchaseOfCommonStock
Cash and equivalentsAt period end2024-06-30$5.1mus-gaap:CashAndCashEquivalentsAtCarryingValue
Current assetsAt period end2024-06-30$11.6mus-gaap:AssetsCurrent
Total assetsAt period end2024-06-30$22.0mus-gaap:Assets
Current liabilitiesAt period end2024-06-30$9.9mus-gaap:LiabilitiesCurrent
Total liabilitiesAt period end2024-06-30$17.1mus-gaap:Liabilities
Long-term debtAt period end2024-06-30$6.8mus-gaap:LongTermDebtNoncurrent
Shareholders' equityAt period end2024-06-30$4.9mus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0001410578-24-001118. Last ingested by Listed: Nov 6, 2026, 18:45 ET. Listed shows no prices and gives no investment advice.